Anastasia Chillà Selected Research

N-succinimidyl 8-((4'-fluorobenzyl)amino)suberate

1/2016

Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anastasia Chillà Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 11/2010
10	Melanoma (Melanoma, Malignant) 11/2021 - 03/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2014
3	Systemic Scleroderma (Systemic Sclerosis) 01/2013 - 08/2010
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021 - 01/2016
2	Inflammation (Inflammations) 04/2015 - 01/2011
1	Bites and Stings (Sting) 01/2022
1	Arthritis (Polyarthritis) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Bone Diseases (Bone Disease) 09/2015
1	Bone Resorption 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 03/2014
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Infections 01/2011
1	Wounds and Injuries (Trauma) 01/2011
1	Pain (Aches) 01/2011
1	Follicular Cyst (Follicular Cysts) 11/2010
1	Jaw Cysts 11/2010
1	Cysts 11/2010

Drug/Important Bio-Agent (IBA)

5	Peptides (Polypeptides)IBA 03/2021 - 01/2012
5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2020 - 11/2010
4	IntegrinsIBA 01/2019 - 03/2014
3	Conditioned Culture MediaIBA 03/2021 - 07/2015
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2020 - 11/2010
3	Peptide Hydrolases (Proteases)FDA Link 04/2018 - 11/2010
3	PlasminogenIBA 01/2017 - 11/2010
2	Plasminogen Activator Inhibitor 1IBA 11/2021 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2019
2	GoldIBA 02/2021 - 06/2016
2	Biological ProductsIBA 01/2021 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2020 - 01/2019
2	EnzymesIBA 01/2017 - 06/2014
1	Lamin Type B (Lamin B)IBA 01/2022
1	PhenolsIBA 01/2022
1	cadherin 5IBA 03/2021
1	Gefitinib (Iressa)FDA Link 03/2021
1	CytokinesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	secukinumabIBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2020
1	tipifarnib (R115777)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	VemurafenibIBA 01/2019
1	ResveratrolIBA 09/2017
1	DNA (Deoxyribonucleic Acid)IBA 09/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	ChitosanIBA 06/2016
1	N-succinimidyl 8-((4'-fluorobenzyl)amino)suberateIBA 01/2016
1	CilengitideIBA 09/2015
1	adhesion receptorIBA 09/2015
1	LigandsIBA 09/2015
1	Antisense OligonucleotidesIBA 07/2015
1	LipidsIBA 04/2015
1	erucylphosphocholineIBA 06/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2014
1	integrin beta8IBA 01/2013
1	Desmoglein 2IBA 01/2013
1	Connective Tissue Growth FactorIBA 01/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2013
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2012
1	BradykininIBA 01/2011
1	Fibrin Fibrinogen Degradation ProductsIBA 01/2011
1	FibrinIBA 01/2011
1	Complement System Proteins (Complement)IBA 01/2011
1	AcidsIBA 01/2011
1	Matrix Metalloproteinase 12IBA 08/2010
1	PTX3 proteinIBA 08/2010

Therapy/Procedure

9	Therapeutics 11/2021 - 06/2014
3	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2020 - 06/2014
2	Immunotherapy 11/2021 - 04/2015
2	Precision Medicine 02/2021 - 06/2014
1	Radiotherapy 01/2022